Table 4 Drug-likeness and bioavailability
From: Molecular binding studies of anthocyanins with multiple antiviral activities against SARS-CoV-2
Compounds | Lipinski #violations | Veber #violations | Bioavailability score |
|---|---|---|---|
C1 | 3 | 1 | 0.17 |
C2 | 3 | 1 | 0.17 |
C3 | 3 | 1 | 0.17 |
C4 | 3 | 1 | 0.17 |
C5 | 3 | 2 | 0.17 |
C6 | 3 | 1 | 0.17 |
C7 | 3 | 1 | 0.17 |
C8 | 3 | 2 | 0.17 |